The Marfan syndrome

Annual Review of Medicine

Volumn 51, Issue , 2000, Pages 481-510

  Pyeritz, Reed E ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Aortic aneurysm; Aortic dissection; Elastic fibers; Fibrillin; Microfibrils; Mitral valve prolapse

Indexed keywords

FIBRILLIN;

AORTA DISSECTION; ARACHNODACTYLY; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ECTOPIA LENTIS; EYE MALFORMATION; GENE MUTATION; HUMAN; LIFE EXPECTANCY; MARFAN SYNDROME; MITRAL VALVE PROLAPSE; MYOPATHY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SKIN DEFECT; TALL STATURE; VASODILATATION;

HUMANS; MARFAN SYNDROME;

EID: 0034050792     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.51.1.481     Document Type: Review

References (133)

1. 1. McKusick VA. 1955. The cardiovascular aspects of Marfan's syndrome: A heritable disorder of connective tissue. Circulation 11:321-342
2. 2. McKusick VA. 1956. Heritable Disorders of Connective Tissue. St Louis, MO: Mosby
3. 3. Marfan A-B. 1896. Un cas de déformation congénitale des quatre membres plus prononcée aux extremites caractérisée par l'allongement des os avec un certain degré d'amincissement. Bull. Mém. Soc. Med. Hop. Paris (Ser. 3) 13:220-26
4. 4. Marfan A-B. 1938. La dolichosténomélie (dolichomélie arachnodactylie). Ann. Med. 44:5-29
5. 5. Weve H. 1931. Über Arachnodaktylie. (Dystrophia mesodermalis congenita, Typus Marfan). Arch. Augenheilkd. 104:1-46
6. 6. Baer RW, Taussig HB, Oppenheimer EH. 1943. Congenital aneurysmal dilatation of the aorta associated with arachnodactyly. Bull. Johns Hopkins Hosp. 72:309-31
7. 7. Etter LE, Glover LP. 1943. Arachnodactyly complicated by dislocated lens and death from rupture of dissecting aneurysm of aorta. JAMA 123:88-89
8. 8. Murdoch JL, Walker BA, Halpern BL, et al. 1972. Life expectancy and causes of death in the Marfan syndrome. N. Engl. J. Med. 286:804-8
9. 9. Dietz HC, Cutting GR, Pyeritz RE, et al. 1991. Defects in the fibrillin gene cause the Marfan syndrome; linkage evidence and identification of a missense mutation. Nature 352:337-39
10. 10. Shores J, Berger KR, Murphy EA, Pyeritz RE. 1994. Chronic β-adrenergic blockade protects the aorta in the Marfan syndrome: a prospective, randomized trial of propranolol. N. Engl. J. Med. 330:1335-41
11. 11. Svensson LG, Crawford ES, Coselli JS, et al. 1989. Impact of cardiovascular operation on survival in the Marfan patient. Circulation (Suppl) 80:233-42
12. 12. Gott VL, Cameron DE, Pyeritz RE, et al. 1994. Composite graft repair of Marfan aneurysm of the ascending aorta: results in 150 patients. J. Card. Surg. 9:482-89
13. 13. Silverman DI, Burton KJ, Gray J, et al. 1995. Life expectancy in the Marfan syndrome. Am. J. Cardiol. 75:157-60
14. 14. Gott VL, Greene PS, Alejo DE, et al. 1999. Replacement of the aortic root in patients with Marfan's syndrome. N. Engl. J. Med. 340:1307-13
15. 15. Pyeritz RE. 1997. Marfan syndrome and other disorders of fibrillin. In Principles and Practice of Medical Genetics, ed. DL Rimoin, JM Connor, RE Pyeritz, pp. 1027-66. New York: Churchill Livingstone. 3rd ed.
16. 16. Glesby MJ, Pyeritz RE. 1989. Association of mitral valve prolapse and systemic abnormalities of connective tissue: a phenotypic continuum. JAMA 262: 523-28
17. 17. Freed LA, Levy D, Levine RA, et al. 1999. Prevalence and clinical outcome of mitral-valve prolapse. N. Engl. J. Med. 341:1-7
18. 18. McKusick VA. 1999. On-line Mendelian Inheritance in Man. www.ncbi.nlm.nih.gov/OMIM
19. 19. Pyeritz RE. 1989. Pleiotropy revisited: molecular explanations of a classic concept. Am. J. Med. Genet. 34:124-34
20. 20. Lipscomb KJ, Clayton-Smith J, Harris R. 1997. Evolving phenotype of Marfan's syndrome. Arch. Dis. Child. 7:41-46
21. 21. Beighton P, de Paepe A, Danks D, et al. 1988. International nosology of heritable disorders of connective tissue, Berlin 1986. Am. J. Med. Genet. 29:581-94
22. 22. DePaepe A, Deitz HC, Devereux RB, Hennekem R, Pyeritz RE. 1996. Revised diagnostic criteria for the Marfan syndrome. Am. J. Med. Genet. 62:417-26
23. 23. Dietz HC, Pyeritz RE. 1995. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum. Molec. Genet. 4:1799-1809
24. 24. Maron BJ, Moller JH, Seidman CE, et al. 1998. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long QT syndrome and Marfan syndrome. Circulation 98:1460-71
25. 25. Pereira L, Levran O, Ramirez F, et al. 1994. A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. N. Engl. J. Med. 331:148-53
26. 26. Rantamäki T, Lönnqvist L, Karttunen L, et al. 1994. DNA diagnostics of the Marfan syndrome: application of amplifiable polymorphic markers. Eur. J. Hum. Genet. 2:66-75
27. 27. Burke LW, Pyeritz RE. 1998. Prenatal diagnosis of connective tissue disorders. In Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment, ed. A Milunsky, pp. 612-34. Baltimore, MD: Johns Hopkins Univ. Press. 4th ed.
28. 28. Godfrey M, Vandemark N, Wang M, et al. 1993. Prenatal diagnosis and a donor splice site mutation in fibrillin in a family with Marfan syndrome. Am. J. Hum. Genet. 53:472-80
29. 29. Kilpatrick MW, Harton GL, Phylactou LA, et al. 1996. Preimplantation genetic diagnosis in Marfan syndrome. Fetal Diagn. Ther. 11:402-6
30. 30. Blaszczyk A, Tang YX, Dietz HC, et al. 1998. Preimplantation genetic diagnosis of human embryos for Marfan's syndrome. J. Asst. Reprod. Genet. 15:281-84
31. 31. Sermon K, Lissens W, Messiaen L, et al. 1999. Preimplantation genetic diagnosis of Marfan syndrome with the use of fluorescent polymerase chain reaction and the automated laser fluorescence DNA sequencer. Fertil. Steril. 71:163-66
32. 32. Eldadah ZA, Grifo JA, Dietz HC. 1995. Marfan syndrome as paradigm for transcript-targeted preimplantation diagnosis of heterozygous mutations. Nat. Med. 1:798-803
33. 33. Dietz HC, Pyeritz RE. 2000. Marfan syndrome and related disorders. In The Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle. New York: McGraw-Hill. 8th ed. In press
34. 34. Scherer LR, Arn PH, Dressel D, et al. 1988. Surgical management of children and young adults with Marfan syndrome and pectus excavatum. J. Pediatr. Surg. 23:1169-72
35. 35. Arn PH, Scherer LR, Haller JA Jr, Pyeritz RE. 1989. Outcome of pectus excavatum in patients with Marfan syndrome and in the general population. J. Pediatr. 115:954-58
36. 36. Nuss D, Kelly RD, Croitoru DP, Katz ME. 1998. A 10-year review of a minimally invasive technique for the correction of pectus excavatum. J. Pediatr. Surg 33:545-52
37. 37. Taylor LJ. 1987. Severe spondylolisthesis and scoliosis in association with Marfan's syndrome: case report and review of the literature. Clin. Orthop. 221:207-11
38. 38. Sponseller PD, Hobbs W, Riley LH III, Pyeritz RE. 1995. The thoracolumbar spine in Marfan syndrome. J. Bone Joint Surg. 77A:867-76
39. 39. Hobbs WR, Sponseller PD, Weiss A-P, Pyeritz RE. 1997. The cervical spine in Marfan syndrome. Spine 22:983-89
40. 40. Sponseller PD, Sethi N, Cameron DE, Pyeritz RE. 1997. Infantile scoliosis in Marfan syndrome. Spine 22:509-16
41. 41. Robins PR, Moe JH, Winter RB. 1975. Scoliosis in Marfan's syndrome: its characteristics and results of treatment in 35 patients. J. Bone Joint Surg. 57A:358-68
42. 42. Gray JR, Bridges AB, Mole PA, et al. 1993. Osteoporosis and the Marfan syndrome. Postgrad. Med. J. 69:373-75
43. 43. Kohlmeier L, Gasner C, Marcus R. 1993. Bone mineral status of women with Marfan syndrome. Am. J. Med. 95:568-72
44. 44. Sponseller PD, Tomek IM, Pyeritz R. 1997. Developmental dysplasia of the hip in the Marfan syndrome. Br. J. Pediatr. Orthop. 6:255-59
45. 45. Kuhlman JE, Scott WW Jr, Fishman EK, et al. 1987. Acetabular protrusion in the Marfan syndrome. Radiology 164:415-17
46. 46. Grahame R, Pyeritz RE. 1995. Marfan syndrome: joint and skin manifestations are prevalent and correlated. Br. J. Rheumatol. 34:126-31
47. 47. Putnam EA, Zhang H, Ramirez F, Milewicz DM. 1995. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. Nat. Genet. 11:456-58
48. 48. Maumenee IH. 1981. The eye in the Marfan syndrome. Trans. Am. Ophthalmol. Soc. 79:684-733
49. 49. Izquierdo NJ, Traboulsi EI, Enger C, Maumenee IH. 1994. Strabismus in the Marfan syndrome. Am. J. Ophthalmol. 117:632-35
50. 50. Sisk HE, Zahka KG, Pyeritz RE. 1983. The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age. Am. J. Cardiol. 52:353-58
51. 51. Morse RP, Rockenmacher S, Pyeritz RE, et al. 1990. Diagnosis and management of Marfan syndrome during infancy. Pediatrics 86:888-89S
52. 52. Pyeritz RE. 1996. The Marfan syndrome in childhood: features, natural history and differential diagnosis. Prog. Pediatr. Cardiol. 5:151-57
53. 53. Roman MJ, Devereux RB, Kramer-Fox R, Spitzer MC. 1989. Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndrome. Am. J. Cardiol. 63:317-21
54. 54. Nishimura RA, McGoon MD. 1999. Perspectives on mitral-valve prolapse. N. Engl. J. Med. 341:48-50
55. 55. Pyeritz RE, Wappel MA. 1983. Mitral valve dysfunction in the Marfan syndrome. Clinical and echocardiographic study of prevalence and natural history. Am. J. Med. 74:797-807
56. 56. Saruk M, Eisenstein R. 1977. Aortic lesion in Marfan syndrome: the ultrastructure of cystic medial degeneration. Arch. Pathol. Lab. Med. 101:74-77
57. 57. Jeremy RW, Huang H, Hwa J, et al. 1994. Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome. Am. J. Cardiol. 74:369-73
58. 58. Schievink WI, Parisi JE, Piepgras DG, Michels VV. 1997. Intracranial aneurysms in Marfan's syndrome: an autopsy study. Neurosurgery 41:866-71
59. 59. Groenink M, Rozendaal L, Naeff MSJ, et al. 1998. Marfan syndrome in children and adolescents: predictive and prognostic value of aortic root growth for screening for aortic complications. Heart 80:163-69
60. 60. Rossi-Foulkes R, Roman MJ, Rosen SE, et al. 1999. Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome. Am. J. Cardiol. 83:1364-68
61. 61. Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J. 1989. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am. J. Cardiol. 64:507-12
62. 62. Reed CM, Richey PA, Puliam DA, et al. 1993. Aortic dimensions in tall men and women. Am. J. Cardiol. 71:608-10
63. 63. Dare AJ, Veinot JP, Edwards WD, et al. 1993. Hum. Pathol. 24:1330-38
64. 64. Lima SD, Lima JAC, Pyeritz RE, Weiss JL. 1985. Relation of mitral valve prolapse to left ventricular size in Marfan's syndrome. Am. J. Cardiol. 55:739-43
65. 65. Pruzinsky MS, Katz NM, Green CE, Satler LF. 1988. Isolated descending thoracic aortic aneurysm in Marfan's syndrome. Am. J. Cardiol. 61:1159-60
66. 66. Maron BJ, Epstein SE, Roberts WC. 1986. Causes of sudden death in competitive athletes. J. Am. Coll. Cardiol. 7:204-14
67. 67. American Academy of Pediatrics. 1996. Health supervision for children with Marfan syndrome. Pediatrics 98:978-82
68. 68. Yin FCP, Brin KP, Ting C-T, Pyeritz RE. 1989. Arterial hemodynamic indexes in Marfan's syndrome. Circulation 79:854-62
69. 69. Reed CM, Alpert BS. 1992. Assessment of ventricular performance after chronic beta-adrenergic blockade in the Marfan syndrome. Am. J. Cardiol. 70:541-42
70. 70. Salim MA, Alpert BS, Ward JC, Pyeritz RE. 1994. Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndrome. Am. J. Cardiol. 74:629-33
71. 71. Legget ME, Unger TA, O'Sullivan CK, et al. 1996. Aortic root complications in Marfan's syndrome: identification of a lower risk group. Heart 75:389-95
72. 72. Haouzi A, Berglund H, Pelikan PCD, et al. 1997. Heterogeneous aortic response to acute β-adrenergic blockade in Marfan syndrome. Am. Heart J. 133:60-63
73. 73. Adams JN, Trent RJ. 1998. Aortic complications of Marfan's syndrome. Lancet 352:1722-23
74. 74. Groenink M, de Roos A, Mulder BJM, et al. 1998. Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am. J. Cardiol. 82:203-8
75. 75. Gillinov AM, Hulyalkar A, Cameron DE, et al. 1994. Mitral valve operation in patients with the Marfan syndrome. J. Thorac. Cardiovasc. Surg. 107:724-31
76. 75a. Jondeau G, Boutouyrie P, Lacolley P, et al. 1999. Central pulse pressure is a major determinant of ascending aorta dilatation in Marfan syndrome. Circulation 99:2677-81
77. 76. David TE, Feindel CM. 1992. An aortic valve-sparing operation for patients with aortic incompetence and aneursym of the ascending aorta. J. Thorac. Cardiovasc. Surg. 103:617-22
78. 76a. Rogers WJ, Hu YL, Coast DA, et al. 1998. Quantification of regional pulse wave velocity in the Marfan aorta using magnetic resonance imaging. J. Am. Coll. Cardiol. 31:165A
79. 77. David TE. 1994. Aortic valve repair in patients with Marfan syndrome and ascending aorta aneurysms due to degenerative disease. J. Card. Surg. 9:18-87 (Suppl.)
80. 78. Yacoub MH, Gehle P, Chandrasekaran V, et al. 1998. Late results of a valve-preserving operation in patients with aneurysms of the ascending aorta and root. J. Thorac. Cardiovasc. Surg. 115:1080-90
81. 79. Silverman DI, Gray J, Roman MJ, et al. 1995. Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival. J. Am. Coll. Cardiol. 26:1062-67
82. 80. Coady MA, Rizzo JA, Hammond GL, et al. 1997. What is the appropriate size criterion for resection of thoracic aortic aneurysms? J. Thorac. Cardiovasc. Surg. 113:476-91
83. 81. Dake MD, Kato N, Mitchell RS, et al. 1999. Endovascular stent-graft placement for the treatment of acute aortic dissection. N. Engl. J. Med. 340:1546-52
84. 82. Williams GM. 1993. Treatment of chronic expanding dissecting aneurysms of the descending thoracic and upper abdominal aorta by extended aortotomy, removal of the dissected intima, and closure. J. Vasc. Surg. 18:441-49
85. 83. Crawford ES, Crawford JL, Stowe CL, Safi HJ. 1984. Total aortic replacement for chronic aortic dissection occurring in patients with and without Marfan's syndrome. Ann. Surg. 199:358-62
86. 84. Durack DT. 1995. Prevention of infective endocarditis. N. Engl. J. Med. 332:38-44
87. 85. Pyeritz RE. 1981. Maternal and fetal complications of pregnancy in the Marfan syndrome. Am. J. Med. 71:784-90
88. 86. Rossiter JP, Morales AJ, Repke JT, et al. 1995. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am. J. Obstet. Gynecol. 173:1599-606
89. 87. Lipscomb KJ, Clayton-Smith J, Clarke B, et al. 1997. Outcome of pregnancy in women with Marfan's syndrome. Br. J. Obstet. Gynaecol. 104:210-16
90. 88. Parida SK, Kriss VM, Hall BD. 1997. Hiatus/paraesophageal hernias in neonatal Marfan syndrome. Am. J. Med. Genet. 72:156-58
91. 89. Pyeritz RE, Fishman EK, Bernhardt BA, Siegelman SS. 1988. Dural ectasia is a common feature of the Marfan syndrome. Am. J. Hum. Genet. 43:726-32
92. 90. Smith MD. 1993. Large sacral dural defect in Marfan syndrome. J. Bone Joint Surg. 75-A:1067-70
93. 91. Hall JR, Pyeritz RE, Dudgeon DL, Haller JA Jr. 1984. Pneumothorax in the Marfan syndrome: prevalence and therapy. Ann. Thorac. Surg. 37:500-4
94. 92. Streeten EA, Murphy EA, Pyeritz RE. 1987. Pulmonary function in the Marfan syndrome. Chest 91:408-12
95. 93. Cistulli PA, Sullivan CE. 1993. Sleep-disordered breathing in Marfan's syndrome. Am. Rev. Resp. Dis. 147:645-48
96. 94. Pagès M, Echenne B, Pagès A-M, et al. 1985. Multicore disease and Marfan's syndrome: a case report. Eur. Neurol. 24:170-75
97. 95. Hofman KJ, Bernhardt BA, Pyeritz RE. 1988. Marfan syndrome: neuropsychological aspects. Am. J. Med. Genet. 31:331-38
98. 96. Lannoo E, De Paepe A, Leroy B, Thiery E. 1996. Neuropsychological aspects of Marfan syndrome. Clin. Genet. 49:65-69
99. 97. Apert E. 1938. Les formes frustes du syndrome dolichosténomélique de Marfan. Nourrisson 26:1-12
100. 98. Lutman FC, Neel JV. 1949. Inheritance of arachnodactyly, ectopia lentis and other congenital anomalies (Marfan's syndrome) in the E. family. Arch. Ophthalmol. 41:276-305
101. 99. Collod-Béroud G, Lackmy-Port-Lys M, Jondeau G, et al. 1999. Demonstration of the recurrence of Marfan-like skeletal and cardiovascular manifestations due to germline mosaicism for an FBN1 mutation. Am. J. Hum. Genet. 65:917-21
102. 100. Murdoch JL, Walker BA, McKusick VA. 1972. Parental age effects on the occurrence of new mutations for the Marfan syndrome. Ann. Hum. Genet. 35:331-36
103. 101. Kartunnen L, Raghunath M, Lönnqvist L, Peltonen L. 1994. A compound heterozygous Marfan patient: two defective fibrillin alleles result in a lethal phenotype. Am. J. Hum. Genet. 55: 1083-91
104. 102. Sakai LY, Keene DR, Engvall E. 1986. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J. Cell Biol. 103:2499-2509
105. 103. Aoyama T, Francke U, Dietz HC, Furthmayr H. 1994. Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. J. Clin. Invest. 94: 130-37
106. 104. Furthmayr H, Francke U. 1997. Acending aortic aneurysm with or without features of Marfan syndrome and other fibrillinopathies: new insights. Sem. Thorac. Cardiovasc. Surg. 9(3):191-205
107. 105. Aoyama T, Francke U, Gasner C, Furthmayr H. 1995. Fibrillin abnormalities and prognosis in Marfan syndrome and related disorders. Am. J. Med. Genet. 58:169-72
108. 106. Kielty CM, Shuttleworth CA. 1994. Abnormal fibrillin assembly by dermal fibroblasts from two patients with the Marfan syndrome. J. Cell Biol. 124:997-1004
109. 107. Dietz H, Francke U, Furthmayr H, et al. 1995. The question of heterogeneity in Marfan syndrome. Nat. Genet. 9:228-29
110. 108. Collod G, Babron M-C, Jondeau G, et al. 1994. A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat. Genet. 8:264-68
111. 109. Collod-Beroud G, Beroud C, Ades L, et al. 1998. Marfan Database (third edition): new mutations and new routines for the software. Nucl. Acids Res. 26:229-33
112. 110. Milewicz DM, Duvic M. 1994. Severe neonatal Marfan syndrome resulting from a de novo 3-bp insertion into the fibrillin gene on chromosome 15. Am. J. Hum. Genet. 54:447-53
113. 111. Wang M, Kishnani P, Decker-Phillips M, et al. 1996. Double mutant fibrillin-1 (FBN1) allele in a patient with neonatal Marfan syndrome. J. Med. Genet. 33: 760-63
114. 112. Rogan KM, Sears-Rogan P, Virmani R, Pyeritz RE. 1989. Familial myxomatous valvular disease. Am. J. Cardiol. 63: 1149-51
115. 113. Montgomery RA, Geraghty MT, Bull E, et al. 1998. Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome. Am. J. Hum. Genet. 63:1703-11
116. 114. Duren DR, Becker AE, Dunning AJ. 1988. Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: a prospective study. J. Am. Coll. Cardiol. 11:42-47
117. 115. Biddinger A, Rocklin M, Coselli J, Milewicz DM. 1997. Familial thoracic aortic dilatations and dissections: a case control study. J. Vasc. Surg. 25:506-11
118. 116. Nicod P, Bloor C, Godfrey M, et al. 1989. Familial aortic dissecting aneurysm. J. Am. Coll. Cardiol. 13:811-19
119. 117. Milewicz DM, Chen H, Park E-S, et al. 1998. Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections. Am. J. Cardiol. 82:474-79
120. 118. Milewicz DM, Michael K, Fisher N, et al. 1996. Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. Circulation 94:2708-11
121. 119. Francke U, Berg MA, Tynan K, et al. 1995. A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection. Am. J. Hum. Genet. 56:1287-96
122. 120. Schrijver I, Liu W, Francke U. 1997. The pathogeneicity of the Pro1148Ala substitution in the FBN1 gene: causing or predisposing to Marfan syndrome and aortic aneurysm, or clinically innocent? Hum. Genet. 99:607-11
123. 121. Kubota J, Tsunemura M, Amano S. et al. 1997. Non-Marfan idiopathic medionecrosis (cystic medial necrosis) presenting with multiple visceral artery aneurysms and diffuse connective tissue fragility: two brothers. Cardiovasc. Intervent. Radiol. 20:225-27
124. 122. Tsipouras P, Del Mastro R, Sarfarazi M, et al. 1992. Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. N. Engl. J. Med. 326:905-9
125. 123. Edwards MJ, Challinor CJ, Colley PW, et al. 1994. Clinical and linkage study of a large family with simple ectopia lentis linked to FBN1. Am. J. Med. Genet. 53:65-71
126. 124. Kainulainen K, Karttunen L, Puhakka L, et al. 1994. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nat. Genet. 6:64-69
127. 125. Milewicz DM, Grossfield J, Cao S-N, et al. 1995. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J. Clin. Invest. 95: 2373-78
128. 126. Viljoen D. 1994. Congenital contractural arachnodactyly (Beals syndrome). J. Med. Genet. 31:640-43
129. 127. Park ES, Putnam EA, Chitayat D, et al. 1998. Clustering of FBN2 mutations in patients with congenital contractural arachnodactyly indicates an important role of the domains encoded by exons 24 through 34 during human development. Am. J. Med. Genet. 78:350-55
130. 128. Babcock D, Gasner C, Francke U, Maslen C. 1998. A single mutation that results in an Asp to His substitution and partial exon skipping in a family with congenital contractural arachnodactyly. Hum. Genet. 103:22-28
131. 129. Putnam EA, Parks ES, Aalfs CM, et al. 1997. Parental somatic and germ-line mosaicism for a FBN2 mutation and analysis of FBN2 transcript levels in dermal fibroblasts. Am. J. Hum. Genet. 60:818-27
132. 130. Sood S, Eldadah ZA, Krause WL, et al. 1996. Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Nat. Genet. 12: 209-11
133. 131. Saal HM, Bulas DI, Allen JF, et al. 1995. Patient with craniosynostosis and marfanoid phenotype (Shprintzen-Goldberg syndrome) and cloverleaf skull. Am. J. Med. Genet. 57: 573-78